NL194637C - Werkwijze voor het vervaardigen van deeltjes, bedoeld voor het over een verloop van tijd afgeven van een effectieve hoeveelheid actief bestanddeel. - Google Patents

Werkwijze voor het vervaardigen van deeltjes, bedoeld voor het over een verloop van tijd afgeven van een effectieve hoeveelheid actief bestanddeel. Download PDF

Info

Publication number
NL194637C
NL194637C NL9101306A NL9101306A NL194637C NL 194637 C NL194637 C NL 194637C NL 9101306 A NL9101306 A NL 9101306A NL 9101306 A NL9101306 A NL 9101306A NL 194637 C NL194637 C NL 194637C
Authority
NL
Netherlands
Prior art keywords
gel
particles
mpa
temperature
lactide
Prior art date
Application number
NL9101306A
Other languages
English (en)
Dutch (nl)
Other versions
NL194637B (nl
NL9101306A (nl
Inventor
Jean-Marc Ruiz
Original Assignee
Sociutu De Conseils De Rech S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sociutu De Conseils De Rech S filed Critical Sociutu De Conseils De Rech S
Publication of NL9101306A publication Critical patent/NL9101306A/nl
Publication of NL194637B publication Critical patent/NL194637B/xx
Application granted granted Critical
Publication of NL194637C publication Critical patent/NL194637C/nl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Glanulating (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL9101306A 1990-08-01 1991-07-30 Werkwijze voor het vervaardigen van deeltjes, bedoeld voor het over een verloop van tijd afgeven van een effectieve hoeveelheid actief bestanddeel. NL194637C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909016885A GB9016885D0 (en) 1990-08-01 1990-08-01 Sustained release pharmaceutical compositions
GB9016885 1990-08-01

Publications (3)

Publication Number Publication Date
NL9101306A NL9101306A (nl) 1992-03-02
NL194637B NL194637B (nl) 2002-06-03
NL194637C true NL194637C (nl) 2002-10-04

Family

ID=10679993

Family Applications (1)

Application Number Title Priority Date Filing Date
NL9101306A NL194637C (nl) 1990-08-01 1991-07-30 Werkwijze voor het vervaardigen van deeltjes, bedoeld voor het over een verloop van tijd afgeven van een effectieve hoeveelheid actief bestanddeel.

Country Status (30)

Country Link
US (1) US5213812A (es)
JP (1) JP2818704B2 (es)
KR (1) KR920003962A (es)
AT (1) AT396425B (es)
AU (2) AU649696B2 (es)
BE (1) BE1004772A3 (es)
CA (1) CA2048270C (es)
CH (1) CH682715A5 (es)
DE (1) DE4125542A1 (es)
DK (1) DK175756B1 (es)
ES (1) ES2046083B1 (es)
FI (1) FI104149B1 (es)
FR (1) FR2665360B1 (es)
GB (1) GB9016885D0 (es)
GR (1) GR1001512B (es)
HK (1) HK33294A (es)
IE (1) IE65124B1 (es)
IN (1) IN178446B (es)
IT (1) IT1251788B (es)
LU (1) LU87982A1 (es)
MA (1) MA22245A1 (es)
MY (1) MY107500A (es)
NL (1) NL194637C (es)
NO (1) NO300158B1 (es)
NZ (1) NZ238981A (es)
OA (1) OA09387A (es)
PT (1) PT98497B (es)
SE (1) SE505734C2 (es)
TN (1) TNSN91067A1 (es)
ZA (1) ZA915565B (es)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
US5569467A (en) * 1993-05-15 1996-10-29 Societe De Conseils De Recherches Et D'applications (S.C.R.A.S.) Process for the preparation of microballs and microballs thus obtained
GB9310030D0 (en) * 1993-05-15 1993-06-30 Scras Dry processed particles and process for the preparation of the same
EP0740548B1 (en) * 1994-02-28 2002-12-04 Nanopharm AG Drug targeting system, method for preparing same and its use
US5980945A (en) * 1996-01-16 1999-11-09 Societe De Conseils De Recherches Et D'applications Scientifique S.A. Sustained release drug formulations
DE19604744A1 (de) 1996-02-09 1997-08-14 Henkel Kgaa Technische Di-/Triglyceridgemische
DE19617137C1 (de) * 1996-04-29 1997-02-27 Henkel Kgaa Verwendung von Copolymerestern für die Herstellung von Mikrosphären
WO1998015263A2 (en) * 1996-10-09 1998-04-16 Takeda Chemical Industries, Ltd. A method for producing a microparticle
MY118835A (en) * 1997-04-18 2005-01-31 Ipsen Pharma Biotech Sustained release compositions and the process for their preparation
WO1999052708A1 (en) 1998-04-13 1999-10-21 Luminex Corporation Liquid labeling with fluorescent microparticles
EA004502B1 (ru) * 1998-12-16 2004-04-29 Авентис Фармасьютикалз Инк. Фармацевтическая композиция антагониста рецептора серотонина и способ ее получения
AU5644400A (en) * 1999-09-24 2001-03-29 Rohm And Haas Company Pellet compositions
US6458387B1 (en) * 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
US7374782B2 (en) 2000-10-27 2008-05-20 Baxter International Inc. Production of microspheres
US20050233945A1 (en) * 2003-07-18 2005-10-20 Larry Brown Methods for fabrication, uses and compositions of small spherical particles of insulin prepared by controlled phase separation
US20080026068A1 (en) * 2001-08-16 2008-01-31 Baxter Healthcare S.A. Pulmonary delivery of spherical insulin microparticles
DK1418890T3 (da) * 2001-08-16 2008-08-11 Baxter Int Drivmiddel-baserede mikropartikelformuleringer
FR2848113B1 (fr) * 2002-12-04 2005-02-25 Oreal Stabilisation de principes actifs aromatiques par des polymeres aromatiques
US20040166077A1 (en) * 2002-12-04 2004-08-26 L'oreal Process for treating keratin materials with aromatic active principles
US20070092452A1 (en) * 2003-07-18 2007-04-26 Julia Rashba-Step Methods for fabrication, uses, compositions of inhalable spherical particles
US20050142205A1 (en) * 2003-07-18 2005-06-30 Julia Rashba-Step Methods for encapsulating small spherical particles prepared by controlled phase separation
US20050048127A1 (en) * 2003-07-22 2005-03-03 Larry Brown Small spherical particles of low molecular weight organic molecules and methods of preparation and use thereof
US20060135277A1 (en) * 2003-09-10 2006-06-22 Marnocha Bendict F Golf club and practice arrangement
FR2865938B1 (fr) * 2004-02-05 2006-06-02 Sod Conseils Rech Applic Formulation retard solide comprenant de l'acetate de triptoreline
US8728525B2 (en) * 2004-05-12 2014-05-20 Baxter International Inc. Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
PT1765294E (pt) * 2004-05-12 2008-12-30 Baxter Healthcare Sa Microesferas de ácido nucleico, sua produção e entrega
WO2005112885A2 (en) * 2004-05-12 2005-12-01 Baxter International Inc. Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1
US8333995B2 (en) * 2004-05-12 2012-12-18 Baxter International, Inc. Protein microspheres having injectable properties at high concentrations
CA2573341A1 (en) * 2004-07-13 2006-02-16 Altairnano, Inc. Ceramic structures for prevention of drug diversion
AU2005271782A1 (en) * 2004-07-13 2006-02-16 Altairnano, Inc. Ceramic structures for controlled release of drugs
WO2006050345A1 (en) * 2004-10-29 2006-05-11 Adhesives Research, Inc. Microscopic tagging system for security identification
AU2006241145B2 (en) * 2005-04-27 2011-04-28 Baxter Healthcare S. A. Surface-modified microparticles and methods of forming and using the same
JP2009505824A (ja) * 2005-08-23 2009-02-12 アルテアナノ インコーポレイテッド 高度な光触媒のリンドープアナターゼTiO2組成物及びその製造方法
US20080020175A1 (en) * 2006-03-02 2008-01-24 Fred Ratel Nanostructured Indium-Doped Iron Oxide
US20080044638A1 (en) * 2006-03-02 2008-02-21 Fred Ratel Nanostructured Metal Oxides
US20080038482A1 (en) * 2006-03-02 2008-02-14 Fred Ratel Method for Low Temperature Production of Nano-Structured Iron Oxide Coatings
US20070281031A1 (en) * 2006-06-01 2007-12-06 Guohan Yang Microparticles and methods for production thereof
MX2009001226A (es) * 2006-08-04 2009-03-20 Baxter Int Composicion basada en microesferas para prevenir y/o revertir la diabetes autoinmune de nuevo inicio.
MX2009003661A (es) * 2006-10-06 2009-04-22 Baxter Int Microcapsulas que contienen microparticulas modificadas en la superficie y metodos para formar y utilizar las mismas.
EP2077821B1 (en) 2006-10-12 2019-08-14 The University Of Queensland Compositions and methods for modulating immune responses
US20090169628A1 (en) * 2006-10-17 2009-07-02 Armark Authentication Technologies, Llc Article and method for focused delivery of therapeutic and/or diagnostic materials
US20080254258A1 (en) * 2007-04-12 2008-10-16 Altairnano, Inc. Teflon® replacements and related production methods
AU2008242842B2 (en) * 2007-04-17 2014-06-05 Baxter Healthcare Sa Nucleic acid microparticles for pulmonary delivery
US9782300B2 (en) 2008-02-01 2017-10-10 Kci Licensing, Inc. Fiber-microsphere bioresorbable composite scaffold for wound healing
ES2554168T3 (es) 2008-04-18 2015-12-16 Baxter International Inc. Composición basada en microesferas para prevenir y/o revertir la diabetes autoinmune de nueva aparición
US8323615B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing multi-phasic dispersions
US20100047292A1 (en) * 2008-08-20 2010-02-25 Baxter International Inc. Methods of processing microparticles and compositions produced thereby
US8367427B2 (en) * 2008-08-20 2013-02-05 Baxter International Inc. Methods of processing compositions containing microparticles
US8323685B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing compositions containing microparticles
US20100078848A1 (en) * 2008-09-29 2010-04-01 Armark Authentication Technologies, Llc Spinneret and method of spinning fiber
US20100291214A1 (en) * 2008-12-23 2010-11-18 Armark Authentication Technologies, Llc Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
WO2010132763A1 (en) * 2009-05-15 2010-11-18 Armark Authentication Technologies, Llc Fiber having non-uniform composition and method for making same
CN107252482A (zh) 2009-05-27 2017-10-17 西莱克塔生物科技公司 具有不同释放速率的纳米载体加工组分
EP2480596A1 (en) * 2009-09-25 2012-08-01 Armark Authentication Technologies, LLC Tissue fiber scaffold and method for making
US20110293701A1 (en) 2010-05-26 2011-12-01 Selecta Biosciences, Inc. Multivalent synthetic nanocarrier vaccines
EP2399931A1 (fr) * 2010-06-22 2011-12-28 Ipsen Pharma S.A.S. Nouveaux composés octapeptidiques et leur utilisation thérapeutique
BR112013010926A2 (pt) 2010-11-01 2016-08-23 Univ Technology Sidney agentes imunomoduladores e seus usos
CN109172819A (zh) 2011-07-29 2019-01-11 西莱克塔生物科技公司 产生体液和细胞毒性t淋巴细胞(ctl)免疫应答的合成纳米载体
EP3149049B1 (en) 2014-05-27 2022-10-26 The University Of Queensland Il-22 for use in treating metabolic disorders
FR3067226B1 (fr) * 2017-06-13 2021-10-08 Rossignol Lange Element de chaussure de ski

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3567650A (en) * 1969-02-14 1971-03-02 Ncr Co Method of making microscopic capsules
US4010125A (en) * 1975-06-12 1977-03-01 Schally Andrew Victor [D-Trp6 ]-LH-RH and intermediates therefor
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
IN167096B (es) * 1985-04-04 1990-09-01 Akzo Nv
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids
GB8705083D0 (en) * 1987-03-04 1987-04-08 Euro Celtique Sa Spheroids
AU4369589A (en) * 1988-10-27 1990-05-03 Abbott Laboratories Controlled-release delivery device, method for producing device, and method of using device

Also Published As

Publication number Publication date
GB9016885D0 (en) 1990-09-12
ES2046083B1 (es) 1994-08-01
GR1001512B (el) 1994-02-28
DK141891A (da) 1992-02-02
HK33294A (en) 1994-04-22
FI913646A0 (fi) 1991-07-31
CH682715A5 (fr) 1993-11-15
OA09387A (fr) 1992-09-15
NL194637B (nl) 2002-06-03
NO912986L (no) 1992-02-03
IE912700A1 (en) 1992-02-12
JP2818704B2 (ja) 1998-10-30
MY107500A (en) 1995-12-30
NO912986D0 (no) 1991-07-31
ATA152591A (de) 1993-01-15
ZA915565B (en) 1992-04-29
SE9102249D0 (sv) 1991-07-26
FI913646A (fi) 1992-02-02
CA2048270C (en) 1997-02-25
NL9101306A (nl) 1992-03-02
AU8146691A (en) 1992-02-06
SE9102249L (sv) 1992-02-02
IN178446B (es) 1997-05-03
BE1004772A3 (fr) 1993-01-26
JPH05178740A (ja) 1993-07-20
CA2048270A1 (en) 1992-02-02
IE65124B1 (en) 1995-10-04
DK141891D0 (da) 1991-07-31
ITMI911953A1 (it) 1993-01-15
FI104149B (fi) 1999-11-30
PT98497B (pt) 1997-10-31
DK175756B1 (da) 2005-02-14
PT98497A (pt) 1992-06-30
LU87982A1 (fr) 1992-04-15
FI104149B1 (fi) 1999-11-30
AU5939394A (en) 1994-06-02
NO300158B1 (no) 1997-04-21
NZ238981A (en) 1992-11-25
GR910100330A (en) 1992-08-31
DE4125542A1 (de) 1992-02-06
FR2665360B1 (fr) 1995-02-10
AU666808B2 (en) 1996-02-22
ITMI911953A0 (it) 1991-07-15
US5213812A (en) 1993-05-25
KR920003962A (ko) 1992-03-27
AT396425B (de) 1993-09-27
ES2046083A1 (es) 1994-01-16
TNSN91067A1 (fr) 1992-10-25
SE505734C2 (sv) 1997-10-06
MA22245A1 (fr) 1992-04-01
IT1251788B (it) 1995-05-26
AU649696B2 (en) 1994-06-02
FR2665360A1 (fr) 1992-02-07

Similar Documents

Publication Publication Date Title
NL194637C (nl) Werkwijze voor het vervaardigen van deeltjes, bedoeld voor het over een verloop van tijd afgeven van een effectieve hoeveelheid actief bestanddeel.
US4130639A (en) Absorbable pharmaceutical compositions based on isomorphic copolyoxalates
Conti et al. Use of polylactic acid for the preparation of microparticulate drug delivery systems
US3773919A (en) Polylactide-drug mixtures
KR100442931B1 (ko) 수용성 펩티드의 서방성 제제 및 그의 제조방법
Dhanaraju et al. Preparation and characterization of injectable microspheres of contraceptive hormones
GB2246514A (en) Sustained release particles preparation
US5569467A (en) Process for the preparation of microballs and microballs thus obtained
JPH04283510A (ja) 薬物学的活性物質の調節的放出のために適した粒状医薬組成物及び上記組成物の製法
PL212531B1 (pl) Kompozycja o przedluzonym uwalnianiu leuproreliny, sposób wytwarzania kompozycji, srodek farmaceutyczny zawierajacy kompozycje i zastosowanie kompozycji, sposób wytwarzania polimeru kwasu mlekowego i kwasu glikolowego i zastosowanie polimeru
US4186189A (en) Absorbable pharmaceutical compositions based on poly(alkylene oxalates)
US20220241212A1 (en) Cariprazine release formulations
JP2009506100A (ja) 製剤
KR101663560B1 (ko) 균일한 서방출성 미립구의 제조방법
AU685094B2 (en) Process for the preparation of microballs and microballs thus obtained
Singh et al. In vitro characterization of methotrexate loaded poly (lactic-co-glycolic) acid microspheres and antitumor efficacy in Sarcoma-180 mice bearing tumor
CA1098443A (en) Absorbable p-dioxanone polymer-drug compositions
ESLAMI et al. Preparation and characterization of estradiol valerate microspheres using biodegradable polymers

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V1 Lapsed because of non-payment of the annual fee

Effective date: 20110201